Global Deep Brain Stimulation In Parkinson`s Disease Market
Healthcare Services

Global Deep Brain Stimulation In Parkinson`s Disease Market Set for Strong Expansion, Reaching $4.48 Billion With 6.4% CAGR by 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the deep brain stimulation in parkinson`s disease market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Deep Brain Stimulation In Parkinson`s Disease Market between 2026 and 2030?

The deep brain stimulation in parkinson’s disease market has demonstrated substantial growth in recent years. It is projected to expand from $3.27 billion in 2025 to $3.49 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. Historically, this growth has been fueled by elements such as the increasing prevalence of Parkinson’s disease, the growing adoption of DBS devices, rising awareness regarding advanced neuromodulation therapies, the expansion of neurosurgical infrastructure, and an increase in overall healthcare spending.

The deep brain stimulation in parkinson’s disease market size is projected for substantial expansion over the upcoming years. By 2030, this market is anticipated to reach $4.49 billion, exhibiting a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the forecast period include an increasing need for individualized neuromodulation treatments, greater investments in both research and clinical studies, improved availability of tele-neurology services, broader reimbursement options, and the growing uptake of MRI-compatible and rechargeable devices. Significant trends anticipated for the forecast period encompass technological progress in closed-loop and directional stimulation systems, novel developments in rechargeable and extended-life implantable pulse generators (IPGs), progress in AI-supported DBS programming, ongoing research and development into less invasive surgical methods, and enhancements in remote patient monitoring and telemedicine functionalities.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30568&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Deep Brain Stimulation In Parkinson`s Disease Market?

An increasing number of individuals diagnosed with Parkinson’s disease is projected to boost the expansion of the deep brain stimulation in Parkinson’s disease market in the future. This condition is a progressive neurological ailment impacting movement, manifested by symptoms like tremors, rigidity, reduced movement speed, and poor balance, resulting from the deterioration of dopamine-generating neurons within the brain. The growth in Parkinson’s disease patient numbers can be attributed to an aging demographic, given that the likelihood of developing the disease substantially increases with age. Deep brain stimulation offers a method to manage Parkinson’s disease through the delivery of focused electrical impulses to distinct areas of the brain, thereby alleviating motor symptoms, enhancing the quality of life, and decreasing reliance on extended medication regimens. As an illustration, the Parkinson’s Foundation, a US-based non-profit organization, reported that approximately 1.1 million individuals in the United States are living with Parkinson’s disease in 2025, a figure anticipated to reach 1.2 million by 2030, alongside nearly 90,000 new diagnoses annually and over 10 million people impacted globally. Consequently, the expanding population of Parkinson’s disease patients is a primary force propelling the growth of the deep brain stimulation in Parkinson’s disease market.

How Is The Deep Brain Stimulation In Parkinson`s Disease Market Organized Into Various Segments?

The deep brain stimulation in parkinson`s disease market covered in this report is segmented –

1) By Product Type: Implantable Pulse Generators (IPGs), Electrodes And Leads, External Programmers, Accessories And Consumables

2) By Technology: Conventional Deep Brain Stimulation (DBS) Systems, Closed Loop Deep Brain Stimulation (DBS) Systems, Wireless Deep Brain Stimulation (DBS) Systems

3) By Service Type: Pre-Surgical Evaluation Services, Surgical Implantation Services, Device Programming Services, Patient Monitoring Services, Maintenance And Follow-Up Services, Rehabilitation Support Services, Tele-Neurology Support Services, Training And Education Services

4) By Application: Tremor Management, Rigidity And Stiffness Management, Bradykinesia (Slow Movement) Management, Dyskinesia Management

5) By End-Users: Hospitals, Ambulatory Surgical Centres, Neurology Clinics

Subsegments:

1) By Implantable Pulse Generators (IPGs): Rechargeable Implantable Pulse Generators, Non-Rechargeable Implantable Pulse Generators, Directional Implantable Pulse Generators

2) By Electrodes And Leads: Cylindrical Electrodes, Directional Electrodes, Stimulation Leads

3) By External Programmers: Handheld External Programmers, Desktop External Programmers, Wireless External Programmers

4) By Accessories And Consumables: Extension Cables, Battery Chargers, Surgical Tool Kits

What Trends Are Expected To Impact The Competitive Landscape Of The Deep Brain Stimulation In Parkinson`s Disease Market?

Leading companies in the deep brain stimulation for Parkinson’s disease market are concentrating on developing advanced products, such as smaller rechargeable implantable pulse generators and integrated remote programming platforms, to improve patient comfort and care accessibility. Miniaturizing rechargeable implantable pulse generators involves designing these battery-powered neurostimulation devices in much smaller, thinner forms to allow for less invasive implantation while still delivering reliable therapeutic electrical pulses over extended periods. For instance, in January 2024, Abbott Laboratories, a US-based multinational medical devices and healthcare company, launched its Liberta RC DBS system. This platform is a miniaturized rechargeable deep brain stimulation system featuring remote programming capabilities, created to treat people living with movement disorders like Parkinson’s disease and essential tremor. The solution also offers the longest recharge interval of any FDA-approved DBS system, needing only 10 recharge sessions a year for most people, and utilizes the NeuroSphere Virtual Clinic to allow patients to communicate with their doctors and receive treatment adjustments from the comfort of their homes.

Who Are The Major Companies Operating In The Deep Brain Stimulation In Parkinson`s Disease Market?

Major companies operating in the deep brain stimulation in parkinson`s disease market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Mayo Foundation for Medical Education and Research, Cleveland Clinic, Renishaw plc, Neuralink Corp., NeuroPace Inc., PINS Medical Co. Ltd., Neurosoft Ltd., BrainsWay Ltd., Medscape, Inomed Medizintechnik GmbH, SceneRay Corporation Ltd., Neuroelectrics Barcelona S.L., Soterix Medical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, NeuroSigma Inc., BrainGate Company Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-in-parkinsons-disease-market-report

Which Region Is Anticipated To See The Fastest Growth In The Deep Brain Stimulation In Parkinson`s Disease Market?

North America was the largest region in the deep brain stimulation in parkinson’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation in parkinson`s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Deep Brain Stimulation In Parkinson`s Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30568&type=smp

Browse Through More Reports Similar to the Global Deep Brain Stimulation In Parkinson`s Disease Market 2026, By The Business Research Company

Deep Brain Stimulation Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-systems-global-market-report

Deep Brain Stimulation Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-device-global-market-report

spinal cord stimulation global market report

https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model